Search PubMed⌕ Search

Biomedical subjects

A Bosch

Publications and source records attributed to A Bosch.

162 records · Page 9Linked to original sources
PubMedDate not supplied

Adsorption-elution with negatively and positively-charged glass powder for the concentration of hepatitis A virus from water.

Two methods based on virus adsorption and elution from glass powder were developed for the concentration of hepatitis A virus (HAV) from large volumes of water. The cytopathogenic pHM-175 strain of HAV was used to test these procedures in tap water, fresh water, sea water and raw sewage. HAV was quantitated by a plaque assay in the FRhK-4 cell line. HAV was concentrated by glass powder adsorption-elution from 20-liter samples with satisfactory efficiencies in all types of water: 100% for tap water, 80% for freshwater, 75% for sea water and 61% for sewage. The charge of glass powder was modified by polyethylenimine treatment to avoid the need to pretreat the sample. Concentration efficiencies of HAV in 20-1 samples through adsorption to and elution from positively-charged glass powder were 100% for tap water, 94% for sea water, and 61% for fresh water and sewage. Both methods were used for the detection of wild-type HAV in raw sewage. Wild-type HAV in concentrated sewage samples was detected by molecular hybridization with a digoxigenin-labelled cDNA probe.

Adsorption↗
PubMedDate not supplied

Biomonitoring study of people living near or working at a municipal solid-waste incinerator before and after two years of operation.

The authors conducted a biomonitoring study in the town of Mataró, Spain, of 104 subjects who lived near (i.e., within 0.5-1.5 km) an incinerator, 97 subjects who lived far (i.e., within 3.5 km-4.0 km) from an incinerator, and 17 workers at a new municipal solid-waste incinerator. The study commenced before the incinerator started functioning in 1995, and 2 y later (1977) the authors undertook the final part of the study. Dioxins, furans, and polychlorinated biphenyls were studied in pooled blood samples (n = 22), and individual blood and urine samples were analyzed for the detection of lead, chromium, cadmium, and mercury. In 1995, dioxin blood levels were low-both among those living close to the incinerator (mean = 13.5 ng international-dioxin toxic equivalents/kg fat) and among those living far away (mean = 13.4 ng international-dioxin toxic equivalents/kg fat). In 1997, dioxin and polychlorinated biphenyl levels had increased in both groups of residents by approximately 25% and 12%, respectively. (The increase in dioxin levels was about 10% when the authors took into account the mean of two repeated quality-control analyses.) Blood lead levels decreased, but no difference was observed for chromium, cadmium, and mercury. Minimal changes were seen among workers. Given the low dioxin stack emissions from this plant (mean = 2.5-0.98 ng international-dioxin toxic equivalents/m3) and that the blood dioxin levels did not depend on distance of residence from the incinerator, it would appear unlikely that the small increase in dioxin blood levels resulted from the incinerator's emissions.

Adolescent↗
PubMedDate not supplied

[Prospects for gene treatment in paediatric neurology].

INTRODUCTION: The current advances in the field of human genetics allow for the development of alternative therapies for the treatment of diseases affecting the central nervous system (CNS). One of the most promising new therapies is the use of therapeutic genes or gene therapy. OBJECTIVE: To briefly review the recent advances for the treatment of diseases affecting the CNS. DEVELOPMENT: We consider the therapeutic strategies currently in study for gene therapy of diseases with neurologic symptoms as monogenic diseases, CNS malignancies and neurodegenerative diseases. We describe the pros and cons of viral, non viral vectors and cell based therapy. CONCLUSIONS: The current gene therapy approaches allow for specific and efficient administration of therapeutic genes to the CNS. Despite the need of optimization of the available vectors, mainly regarding to safety and efficacy, gene therapy has an important potential for the treatment of neuropediatric diseases.

Adenoviridae Infections↗